ANNONCE

PRM / LEO Pharma strengthens global leadership team with appointment of new Executive Vice President, Global Therapeutic & Value Strategy

23. september 2020 10:01 | Af: Ritzau Info
 

Ballerup, September 23, 2020 – LEO Pharma A/S today announced that Becki
Morison will join the Global Leadership Team as Executive Vice President, Global Therapeutic & Value Strategy, effective October 1.

Pressemeddelelse fra LEO Pharma

Morison joins LEO Pharma from Eli Lilly, where she was VP, US Immunology. Prior to that, she held several leadership positions in the US, Australia as well as in the United Kingdom and the Nordics. In addition to her international experience, Morison has a proven track record in building and growing innovative pharmaceutical

franchises in different therapeutic areas including orphan diseases.

“Becki Morison’s broad knowledge in immunology, dermatology and specialty pharma will help us to strategically develop our innovative portfolio and execute global launches of best or first-in-class medicines, which is essential to reach our ambition of becoming a global leader in medical dermatology,” said Catherine Mazzacco, President and CEO of LEO Pharma.

Morison succeeds Patrice Baudry, who will take over responsibility for establishing LEO Pharma’s rare disease presence.

“Patrice Baudry’s medical background and his experience in building strong value propositions for our medicines, as he did successfully for our thrombosis business, will be vital in establishing LEO Pharma in rare dermatologic diseases,” Mazzacco continued.

Kontakt:

Henrik Kyndlev
hdtdk@leo-pharma.com
+45 3140 6180

Læs hele pressemeddelelsen på Via Ritzau her: https://via.ritzau.dk/pressemeddelelse/leo-pharma-strengthens-global-leadership-team-with-appointment-of-new-executive-vice-president-global-therapeutic-value-strategy?releaseId=13600535

** Ovenstående pressemeddelelse er videreformidlet af Ritzau på vegne af tredjepart. Ritzau er derfor ikke ansvarlig for indholdet **

ANNONCE

ANNONCE
Del din kommentar
Forsiden lige nu